In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."
The National Osteoporosis Foundation (NOF) named five new members to its Board of Trustees during the International Symposium on Osteoporosis, its annual meeting yesterday. NOF is proud to welcome Franmarie Kennedy; Joan M. Lappe PhD, RN, FAAN; C. Berdon Lawrence; Meryl S. LeBoff, M.D.; and C. Michael Lewiecki, M.D., FACP, FACE, FACP as new trustees.
The nation’s top osteoporosis researchers and clinicians will gather in Orlando, Florida this week for the National Osteoporosis Foundation’s (NOF) International Symposium on Osteoporosis (ISO12): Translating Research into Clinical Practice. Held annually, the meeting is the premier scientific event entirely dedicated to the treatment and study of osteoporosis and aims to close the gap between osteoporosis research and its application in clinical practice. As the 2012 recipient of the Lawrence G.
(Banff, Canada, April 22, 2012) Together with the National Osteoporosis Foundation (NOF), CMH Summer Adventures is pleased to invite women across California to attend Using Travel to Jump Start Change: A Conversation with Marybeth Bond. In support of NOF’s Generations of Strength: A Mothers and Daughters Campaign, best-selling author Marybeth Bond will explore travel as a way to move one’s life forward – from fitness to relationships. Don’t miss this opportunity to hear directly from Marybeth on “what makes life meaningful,” simple ways to contribute to a cause greater than yourself and how adventures of a lifetime can also be a great way to reconnect with a daughter or close friend.
DXA Not Necessary for Women Under Age 65 and Men Under Age 70 with No Osteoporosis Risk Factors, but Remains Widely Underutilized among those with Highest Fracture Risk.
DXA Not Necessary for Women Under Age 65 and Men Under Age 70 with No Osteoporosis Risk Factors, but Remains Widely Underutilized among those with Highest Fracture Risk
In this session, Dr. Khosla will explore the future of osteoporosis therapies including new pathways under investigation and other promising therapeutic agents in development.
Estrogen plays a key role in building and maintaining bone in both men and women. Other sex hormones will be discussed as well to show the different effects each has in the body. It may be possible to use levels of follicle stimulating hormone (FSH) in the blood as a marker to estimate the degree of bone loss during menopause.
Osteoporosis is a disease characterized by weakened and fragile bone tissue, leading to an increased chance of breaking a bone. The weakened tissue is due to changes in the amount and structure of bone. While people with osteoporosis are most likely to break bones in the spine, hip or wrist, almost any bone can be affected. These bone breaks often occur with minor accidents such as falls, or banging into objects, but can even occur after no accident at all.
WASHINGTON, DC (May 12, 2011) – A faculty of internationally-renowned osteoporosis experts are gathering next week to share the latest clinically-relevant information on osteoporosis prevention, diagnosis and treatment at the National Osteoporosis Foundation’s (NOF) 9th International Symposium on Osteoporosis (ISO9): Translating Research Into Clinical Practice, May 18 -21 at The Cosmopolitan™ of Las Vegas in Las Vegas, NV. Held annually, ISO9 aims to bridge the gap between osteoporosis research and its application in clinical practice.
WASHINGTON, DC (May 5, 2011) – The National Osteoporosis Foundation (NOF) will honor Mercedes Ellington, dancer, choreographer and granddaughter of “Duke” Ellington, at its Silhouette Awards Dinner on Thursday, May 19 at The Cosmopolitan™ of Las Vegas. Other honorees include Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Stephen I. Katz, M.D., Ph.D.; C. Conrad Johnston, Jr., M.D. of the Indiana University School of Medicine; and patient advocate, Sally Fullman, Ph.D.